The Elevated Health Podcast
In this episode, Amanda Jones breaks down the emerging conversation around GLP‑1 medications and autoimmune disease, emphasizing that GLP‑1s are not a cure for autoimmune conditions but may influence symptoms. She explains what autoimmune disease is, why different autoimmune illnesses behave differently, and why disease‑specific treatment from a specialist remains essential. Amanda outlines how metabolic factors—like insulin resistance, visceral fat, blood sugar swings, sleep, stress, and nutrient status—can amplify inflammation and make autoimmune symptoms worse. The episode reviews how GLP‑1 receptor agonists work, how they can improve insulin sensitivity, reduce appetite and weight, and potentially have anti‑inflammatory effects, while noting these benefits are often indirect and not a replacement for immunomodulatory therapies. Practical safety points covered include GI side effects, effects on medication absorption, the importance of adequate protein and nutrients, preserving muscle with resistance exercise, monitoring labs, and coordinating care with your specialist. Key takeaway: consider whether metabolic drivers are raising your inflammatory burden and discuss thoughtful, individualized care with your healthcare team rather than expecting GLP‑1s to be a universal autoimmune treatment.
50 afleveringen
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de The Elevated Health Podcast community!